Stay updated on Pepinemab for Pediatric Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pepinemab for Pediatric Solid Tumors Clinical Trial page.

Latest updates to the Pepinemab for Pediatric Solid Tumors Clinical Trial page
- Check7 days agoChange DetectedMinor UI/formatting updates observed on the study page, with no changes to core content, eligibility criteria, endpoints, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check14 days agoNo Change Detected
- Check36 days agoChange DetectedUpdated operating-status notice and new BRD resource added; version bumped to v3.2.0. Existing revision v3.1.0 was removed in favor of v3.2.0.SummaryDifference2%

- Check43 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.1%

- Check57 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.1%

- Check64 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.1%

- Check71 days agoChange DetectedThe web page has been updated to include specific facility names and locations, as well as a new study on pepinemab, while removing some previous location details and references to genetic disease resources.SummaryDifference3%

Stay in the know with updates to Pepinemab for Pediatric Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pepinemab for Pediatric Solid Tumors Clinical Trial page.